Literature DB >> 15234837

HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?

Dan H Barouch1, Norman L Letvin.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15234837     DOI： 10.1016/S0140-6736(04)16609-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.

Authors:  Marit J van Gils; Diana Edo-Matas; Emma J Bowles; Judith A Burger; Guillaume B Stewart-Jones; Hanneke Schuitemaker
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

2.  Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing.

Authors:  Benjamin N Bimber; Dawn M Dudley; Michael Lauck; Ericka A Becker; Emily N Chin; Simon M Lank; Haiying L Grunenwald; Nicholas C Caruccio; Mark Maffitt; Nancy A Wilson; Jason S Reed; James M Sosman; Leandro F Tarosso; Sabri Sanabani; Esper G Kallas; Austin L Hughes; David H O'Connor
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques.

Authors:  Benjamin N Bimber; Benjamin J Burwitz; Shelby O'Connor; Ann Detmer; Emma Gostick; Simon M Lank; David A Price; Austin Hughes; David O'Connor
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.

Authors:  Pritha Sen; William A Charini; Ramu A Subbramanian; Edwin R Manuel; Marcelo J Kuroda; Patrick A Autissier; Norman L Letvin
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

5.  Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.

Authors:  Barbara Ridolfi; Domenico Genovese; Claudio Argentini; Maria Teresa Maggiorella; Leonardo Sernicola; Stefano Buttò; Fausto Titti; Alessandra Borsetti; Barbara Ensoli
Journal:  Virus Genes       Date:  2007-11-30       Impact factor: 2.332

6.  The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.

Authors: 
Journal:  PLoS Med       Date:  2005-01-18       Impact factor: 11.069

7.  The aftermath of the Merck's HIV vaccine trial.

Authors:  Enrico Iaccino; Marco Schiavone; Giuseppe Fiume; Ileana Quinto; Giuseppe Scala
Journal:  Retrovirology       Date:  2008-07-02       Impact factor: 4.602
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.